Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
-8.21x3.83x-0.21x3.56x-6.58x-6.18x-.--% 2.04B
15.79x1.84x-2.29x3.41x9.2x10.07x0.64% 62.05B
26.92x4.05x2.05x5.45x15.93x20.03x0.59% 54.52B
33.97x6.85x0.65x11.5x21.69x25.68x-.--% 41.55B
-52.51x2.39x0.42x3.11x9.2x10.73x3.5% 39.06B
31.74x1.56x-1.07x3.42x10.51x12.23x-.--% 29.02B
-7.4x4.36x-0.39x10.45x-6.37x-6.04x-.--% 25.38B
14.83x2.92x4.42x2.6x8.05x7.85x-.--% 19.62B
47.78x4.83x0.25x5.2x36.07x33.32x-.--% 16.89B
24.64x3.45x0.02x5.1x13.75x19.14x-.--% 15.89B
-30.46x-5.28x0.72x14.24x-43.29x-45.01x-.--% 12.98B
-127.09x13268.01x2.74x12.97x-114.9x-126.25x-.--% 12.89B
64.68x26.37x0.61x39.33x55.62x57.37x0.14% 12.37B
15.53x - 0.16x3.36x12.3x14.74x-.--% 10.57B
45.14x - 3.55x - - - -.--% 10.26B
11.97x1.04x0.41x1.82x7.34x9.84x2.8% 6.38B
-43.28x - -0.78x - - - - 5.45B
-108.43x - 7.18x - - - -.--% 5.33B
55.98x3.96x-0.72x - - - - 5.32B
12.8x1.18x-0.19x2.15x5.63x6.73x1.75% 5.18B
Average 1.22x 833.21x 0.88x 7.98x 2.13x 2.77x 0.52% 19.64B
Weighted average by Cap. 7.72x 477.37x 0.47x 7.09x 7.28x 8.64x 0.62%
Biopharmaceuticals
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!